Cell Therapy

Cryoport Systems is the expert partner for advanced therapy programs and critical biologics backed by longstanding logistics excellence and our comprehensive platform of supply chain solutions. The path from scientific discovery to an approved therapy is lengthy and intricate, requiring close oversight of the supply chain at each step. Developers of novel treatments need a strategic partner with expertise in managing the specialized demands of cell therapies to help guide their programs to success.

Cryoport Systems offers an integrated yet agile supply chain platform of services and solutions, mitigating risks through every phase of development. With decades of experience enabling innovative life science breakthroughs, we understand the level of collaboration and forward-thinking needed to reach success. Our platform of products, services, processes, and technologies is designed to mitigate risk at every step and has been specifically focused on serving our biopharmaceutical clients as they overcome challenges within the temperature-controlled supply chain.

At Cryoport Systems, our longstanding dedication to quality and specific focus on the life sciences industry have made us a trusted leader in comprehensive temperature-controlled supply chain solutions. We have earned our credibility by successfully supporting hundreds of clinical trials and delivering over half a million shipments of sensitive, valuable, and often irreplaceable commodities across the globe.

We drive best practices in the life sciences industry, and our experts have served as key contributors in developing ISO standards, including ISO 21973, titled General Requirements for Transportation of Cells for Therapeutic Use. We work closely with ISTA, IATA, ASTM, and other internationally recognized and accredited bodies to design, develop, and execute verification and validation studies. We stand at the forefront of traceability in the biopharmaceutical supply chain, meeting GMP and GDP standards and playing a vital role in defining the compliance processes that will enable the next era of advanced medicine.